1 rich Libsyn https://www.libsyn.com 90 600 In this episode I speak with Psychiatrist and researcher Dr. Angela Reiersen about her recent publication in JAMA, &quot;Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19.&quot; We discuss:&amp;nbsp; -How she stays focused and gets things done -Her research on fluvoxamine (an antidepressant) and COVID-19 -Why we need to go beyond the serotonin receptor in depression -What the sigma 1 receptor is, and why it matters -How sigma 1 agonists may reduce inflammation -The need for a wider view of antidepressant mechanisms -The importance of the connection between inflammation and depression -How understanding newmolecular patterns of depression opens the door to treatment -The importance of executive function interventions for children -How sleep may improve executive functions Get the STUCK Out http://getthestuckout.libsyn.com/website <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/17713838/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/94460741